Siobhan O. Burns

Siobhan O. Burns

Auto-generated profile, based on publicly available information

Siobhan O. Burns

Institute of Immunity and Transplantation, University College London, London, United Kingdom

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2012 in Bioinformatics
Verified
Journal Article
Open access
PDF file
VPVincent Plagnol
Vincent Plagnol
JCJames Curtis
James Curtis
MEMichael Epstein
Michael Epstein
KMKin Y. Mok
Kin Y. Mok
ESEmma Stebbings
Emma Stebbings
SNSergey Nejentsev
Sergey Nejentsev
Motivation: Exome sequencing has proven to be an effective tool to discover the genetic basis of Mendelian disorders. It is well established that copy number variants (CNVs) contribute to the etiology of these disorders. However, calling CNVs from exome sequence data is challenging. A typical read depth strategy consists of using another sample (or a combination of samples) as a reference to control for the variability at the capture and sequencing steps. However, technical variability between samples complicates the analysis and can create spurious CNV calls. Results: Here, we introduce ExomeDepth, a new CNV calling algorithm designed to control for this technical variability. ExomeDepth uses a robust model for the read count data and uses this model to build an optimized reference set in order to maximize the power to detect CNVs. As a result, ExomeDepth is effective across a wider range of exome datasets than the previously existing tools, even for small (e.g. one to two exons) and heterozygous deletions. We used this new approach to analyse exome data from 24 patients with primary immunodeficiencies. Depending on data quality and the exact target region, we find between 170 and 250 exonic CNV calls per sample. Our analysis identified two novel causative deletions in the genes GATA2 and DOCK8. Availability: The code used in this analysis has been implemented into an R package called ExomeDepth and is available at the Comprehensive R Archive Network (CRAN). Contact: v.plagnol@ucl.ac.uk Supplementary Information: Supplementary data are available at Bioinformatics online.

1 February 2017 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Open access
TCTanya I. Coulter
Tanya I. Coulter
ACAnita Chandra
Anita Chandra
CBChris M. Bacon
Chris M. Bacon
JBJudith Babar
Judith Babar
JCJames Curtis
James Curtis
ACAndrew James Cant
Andrew James Cant
Activated phosphoinositide 3-kinase δ syndrome (APDS) is a recently described combined immunodeficiency resulting from gain-of-function mutations in PIK3CD, the gene encoding the catalytic subunit of phosphoinositide 3-kinase δ (PI3Kδ). We sought to review the clinical, immunologic, histopathologic, and radiologic features of APDS in a large genetically defined international cohort. We applied a clinical questionnaire and performed review of medical notes, radiology, histopathology, and laboratory investigations of 53 patients with APDS. Recurrent sinopulmonary infections (98%) and nonneoplastic lymphoproliferation (75%) were common, often from childhood. Other significant complications included herpesvirus infections (49%), autoinflammatory disease (34%), and lymphoma (13%). Unexpectedly, neurodevelopmental delay occurred in 19% of the cohort, suggesting a role for PI3Kδ in the central nervous system; consistent with this, PI3Kδ is broadly expressed in the developing murine central nervous system. Thoracic imaging revealed high rates of mosaic attenuation (90%) and bronchiectasis (60%). Increased IgM levels (78%), IgG deficiency (43%), and CD4 lymphopenia (84%) were significant immunologic features. No immunologic marker reliably predicted clinical severity, which ranged from asymptomatic to death in early childhood. The majority of patients received immunoglobulin replacement and antibiotic prophylaxis, and 5 patients underwent hematopoietic stem cell transplantation. Five patients died from complications of APDS. APDS is a combined immunodeficiency with multiple clinical manifestations, many with incomplete penetrance and others with variable expressivity. The severity of complications in some patients supports consideration of hematopoietic stem cell transplantation for severe childhood disease. Clinical trials of selective PI3Kδ inhibitors offer new prospects for APDS treatment.

1 January 2017 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
KCKeren J. Carss
Keren J. Carss
GAGavin Arno
Gavin Arno
MEMarie Erwood
Marie Erwood
JSJonathan Stephens
Jonathan Stephens
ASAlba Sanchis-Juan
Alba Sanchis-Juan
PYPing Yu
Ping Yu

1 March 2010 in Nature Reviews Immunology
Verified
Journal Article
Closed access
ATAdrian J. Thrasher
Adrian J. Thrasher
SBSiobhan O. Burns
Siobhan O. Burns

15 August 2001 in Blood
Verified
Journal Article
Closed access
PDF file
SBSiobhan Burns
Siobhan Burns
ATAdrian J. Thrasher
Adrian J. Thrasher
MBMichael P. Blundell
Michael P. Blundell
LMLaura M. Machesky
Laura M. Machesky
GJGareth E. Jones
Gareth E. Jones
The cellular mechanisms that configure the cytoskeleton during migration of dendritic cells (DCs) are poorly understood. Immature DCs assemble specialized adhesion structures known as podosomes at their leading edge; these are associated with the localized recruitment of the Wiskott-Aldrich Syndrome protein (WASp) and the actin organizing actin-related protein 2/3 complex. In immature DCs lacking WASp, podosomes are absent, residual dysmorphic lamellipodia and filopodia are nonpolarized, and migration is severely compromised. Microinjection studies indicate that podosome assembly and polarization require concerted action of Cdc42, Rac, and Rho, thereby providing a link between sequential protrusive and adhesive activity. Formation of podosomes is restricted to cells with an immature phenotype, indicating a specific role for these structures during the early migratory phase.

1 January 2016 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
LGLaura Gámez-Díaz
Laura Gámez-Díaz
DADietrich August
Dietrich August
PSPolina Stepensky
Polina Stepensky
SRShoshana Revel-Vilk
Shoshana Revel-Vilk
MSMarkus G. Seidel
Markus G. Seidel
BGBodo Grimbacher
Bodo Grimbacher